All About Science - Going from Research Discovery to Clinical Product April 6, 2011

Whether your goal is to develop your pipeline through commercial launch, or partner as early as possible, submitting an IND is a critical early milestone. Even with big pharma and VC firms competing for the most promising compounds, the bar is still quite high and startups are expected to demonstrate a solid plan for achieving IND acceptance to be taken seriously. Join us for a series of presentations followed by an interactive panel discussion exploring the basic requirements and considerations you must be aware of when planning for a successful IND submission.

Presentations will highlight the following:
* Key components of the Chemistry/Manufacturing/Controls
o Expression, Purification, Analytics, Formulation, Fill/Finish
* Preclinical study design, species selection, material requirements, timelines and cost considerations
* Regulatory requirements, strategies to minimize costs and timelines while balancing risk
* Tips for presenting an attractive package for acquisition

Official Website: http://allaboutscience.eventbrite.com